| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
491,390,000 |
| Market
Cap: |
9.02(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$8.6 - $18.45 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 8.5 |
| Insider 6 Months : 12.5 |
| Insider 3/6 Months : 21.4 |
|
| Guru Rank Number : 235 |
| Guru Rank Value : 5.2 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Elanco Animal Health is an animal health company. Co. groups its products into four principal categories: Companion Animal (CA) Disease Prevention, which includes parasiticides and vaccine products for canines and felines; CA Therapeutics, which includes products for the treatment of pain, osteoarthritis, otitis, cardiovascular and dermatology indications in canines and felines; Food Animal (FA) Future Protein and Health, which includes vaccines, antibiotics, parasiticides and other products used in poultry and aquaculture production; and FA Ruminants and Swine, which includes vaccines, antibiotics, implants, parasiticides and other products used in ruminants and swine production.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
15,000 |
53,100 |
53,100 |
152,300 |
| Total Buy Value |
$254,700 |
$872,502 |
$872,502 |
$2,216,881 |
| Total People Bought |
1 |
3 |
3 |
7 |
| Total Buy Transactions |
1 |
4 |
4 |
11 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-14 |
2023-12-12 |
2023-06-13 |
2022-06-13 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kochevar Deborah Turner |
Director |
– • – |
2019-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
5,233 |
9,016 |
|
- |
|
| Bilbrey John P |
Director |
– • – |
2019-11-22 |
4 |
B |
$26.58 |
$100,100 |
I/I |
3,766 |
11,642 |
2.1 |
- |
|
| Urbanek David Alan |
See Remarks |
• – – |
2019-11-18 |
4 |
B |
$26.21 |
$5,986 |
I/I |
228 |
76 |
1.99 |
- |
|
| Meer James M |
Chief Accounting Officer |
• – – |
2019-10-01 |
4 |
D |
$26.17 |
$15,964 |
D/D |
(610) |
5,102 |
|
- |
|
| Kochevar Deborah Turner |
Director |
– • – |
2019-09-11 |
4 |
B |
$27.95 |
$27,950 |
D/D |
1,000 |
3,783 |
2.39 |
- |
|
| Simmons Jeffrey N |
President, CEO & Director |
• • – |
2019-09-04 |
4 |
B |
$26.55 |
$2,011,163 |
D/D |
75,750 |
470,006 |
2.81 |
- |
|
| Young Todd S. |
See Remarks |
• – – |
2019-09-04 |
4 |
B |
$26.57 |
$265,700 |
D/D |
10,000 |
28,883 |
2.74 |
- |
|
| Hicks Michael-Bryant |
See Remarks |
• – – |
2019-08-22 |
4 |
B |
$26.65 |
$293,905 |
D/D |
11,030 |
33,936 |
2.74 |
- |
|
| Hoover R David |
Director |
– • – |
2019-08-22 |
4 |
B |
$26.96 |
$404,400 |
I/I |
15,000 |
15,920 |
2.1 |
- |
|
| Meer James M |
Chief Accounting Officer |
• – – |
2019-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
475 |
5,712 |
|
- |
|
| Garcia Art A |
Director |
– • – |
2019-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,819 |
2,819 |
|
- |
|
| Harrington Michael J |
Director |
– • – |
2019-04-22 |
4 |
B |
$26.75 |
$93,608 |
D/D |
3,500 |
6,283 |
2.39 |
- |
|
| Anand Kapila K |
Director |
– • – |
2019-04-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,783 |
5,779 |
|
- |
|
| Bilbrey John P |
Director |
– • – |
2019-04-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,783 |
2,783 |
|
- |
|
| Kochevar Deborah Turner |
Director |
– • – |
2019-04-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,783 |
2,783 |
|
- |
|
| Pollard-Knight Denise |
Director |
– • – |
2019-04-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,783 |
2,783 |
|
- |
|
| Hoover R David |
Director |
– • – |
2019-04-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,783 |
14,579 |
|
- |
|
| Kurzius Lawrence Erik |
Director |
– • – |
2019-04-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,783 |
14,579 |
|
- |
|
| Mcdonald Kirk P |
Director |
– • – |
2019-04-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,783 |
2,783 |
|
- |
|
| Harrington Michael J |
Director |
– • – |
2019-04-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,783 |
2,783 |
|
- |
|
| Hoover R David |
Director |
– • – |
2019-03-13 |
4 |
B |
$31.43 |
$628,586 |
I/I |
20,000 |
20,000 |
2.1 |
- |
|
| Urbanek David Alan |
See Remarks |
• – – |
2019-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
35,433 |
49,433 |
|
- |
|
| Lin Sarena S |
See Remarks |
• – – |
2019-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
28,698 |
61,813 |
|
- |
|
| Schacht Aaron L |
See Remarks |
• – – |
2019-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
36,424 |
50,348 |
|
- |
|
| Cabral Ramiro Martin |
See Remarks |
• – – |
2019-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
20,039 |
32,780 |
|
- |
|
391 Records found
|
|
Page 14 of 16 |
|
|
0.11 (0.6%) 
